Recent news on Tigecycline

Astellas Pharma: telavancin enters EU battle for MRSA market share  -  May 2, 2007
Pharmaceutical Business Review...shows limited tissue penetration and requires patient monitoring but dosed once daily) and Wyeth’s Tygacil (tigecycline, good empiric activity apart

Efficacy of Tigecycline Compared to Levofloxacin for Treating ...  -  Apr 5, 2007
DG NewsFurther, in the patients with CAP and Streptococcus pneumoniae bacteraemia, tigecycline achieved clinical cure rates similar to those seen in

GSK meet no resistance for new antibacterial  -  Apr 16, 2007
DrugResearcher.com,In recent months, new antibiotics from the likes of Wyeth (Tygacil; tigecycline) Pfizer (Zyvox; linezolid) and Novartis/Cubist (Cubicin; daptomycin) have

Scientific Results Presented at ECCMID Demonstrate Well ...  -  Apr 5, 2007
WebWire (press release),In vitro activity of ceftobirpole, dalbavancin and tigecycline against methicillin-resistant Stahpylococcus aureus strains from hospital patients in Belgium

Scientific Results Presented At ECCMID Demonstrate Well ...  -  Apr 3, 2007
PharmaLive.com (press release),P784 In vitro activity of ceftobiprole, dalbavancin and tigecycline against methicillin-resistant Staphylococcus aureus strains from hospitalised patients

Scientific Results Presented At ECCMID Demonstrate Well ...  -  Apr 2, 2007
Primenewswire (press release),D. Balis, R. Strauss, B. Murthy, H. Tiian, G. Noel (Raritan, US) P784 In vitro activity of ceftobiprole, dalbavancin and tigecycline against

Antibacterials: narrow-spectrum strategy could change market  -  Mar 29, 2007
Pharmaceutical Business ReviewSince the majority of more recently introduced hospital antibacterials are broad spectrum agents - such as Wyeth's Tigecycline and Cubist/Novartis'

New Antibiotic Now Available to Battle MRSA and Other Superbugs in ...  -  Mar 7, 2007
PharmaLive.com (press release),MARKHAM, ON, March 6, 2007 - Wyeth Pharmaceuticals today announced that TygacilTM(tigecycline), a new intravenous (IV) antibiotic with a broad spectrum of

New antibiotic now available to battle MRSA and other superbugs in ...  -  Mar 7, 2007
Canada NewsWire (press release),MORTALITY CAUSED BY SUPERBUGS MARKHAM, ON, March 7 /CNW/ - Wyeth Pharmaceuticals today announced that Tygacil(TM)(tigecycline), a new intravenous (IV)

New Antibiotic Now Available to Battle MRSA and Other Superbugs in ...  -  Mar 6, 2007
PharmaLive.com (press release),MARKHAM, ON, March 6 /CNW/ - Wyeth Pharmaceuticals today announced that Tygacil(R) (tigecycline), a novel intravenous (IV) antibiotic with a broad spectrum

New antibiotic now available to battle MRSA and other superbugs in ...  -  Mar 6, 2007
Canada NewsWire (press release),MORTALITY CAUSED BY SUPERBUGS MARKHAM, ON, March 6 /CNW/ - Wyeth Pharmaceuticals today announced that Tygacil(R) (tigecycline), a novel intravenous (IV)

Wyeth kicks off CMO agreement with Crucell  -  Dec 20, 2006
OutSourcing-Pharma.com,Prevnar (Pneumococcal 7-valent Conjugate Vaccine) for the prevention of serious pneumococcal diseases in young children, and Tygacil (tigecycline IV) a

Superbug Warning: New Report Warns MRSA Is Reaching Epidemic ...  -  Dec 15, 2006
Medical News Today (press release),Tigecycline is one of a limited number of new broad-spectrum antibiotics available in Europe which can be used when the causative bacteria are still unknown.(6 ...

Wyeth kicks off CMO agreement with Crucell  -  Dec 20, 2006
In-PharmaTechnologist.com,Prevnar (Pneumococcal 7-valent Conjugate Vaccine) for the prevention of serious pneumococcal diseases in young children, and Tygacil (tigecycline IV) a new ...

Superbug Warning: New Report Warns MRSA is Reaching Epidemic ...  -  Dec 12, 2006
Earthtimes.orgTigecycline is one of a limited number of new broad-spectrumantibiotics available in Europe which can be used when the causative bacteriaare still unknown.(6). ...

Many Diagnostics (eg, Phenotypic Tests, Molecular Tests) Are Now ...  Nov 7, 2006
...use of current drugs? Will it increase or decrease use of drugs such as daptomycin, linezolid, and tigecycline? -- Impact of drug ... -Genetic Engineering News (press release), Foro de Shell Security - Seguridad informática  Oct 26, 2006
These oncogenes can be activated by tigecycline chromosomal translocations (ie, the genetic hallmark of lymphoid tikosyn alignancies), or tumor suppressor loci ... -Shell Security, Most infections acquired in ICU, study reveals  Sep 14, 2006
...treatments because of the high cost. This fall, a new antibiotic, tigecycline, will be available in Canada. It has been used in ... -Winnipeg Free Press (subscription)

Superbug Warning: New Report Warns MRSA is Reaching Epidemic ...  -  12 Dec 2006
netPR.pl (komunikaty prasowe),Tigecycline is one of a limited number of new broad-spectrum antibiotics available in Europe which can be used when the causative bacteria are still unknown

Broad Spectrum Antibiotic Available for Antibiotic Resistant ...  22 Jul 2006
Tygacil (tigecycline)is a new, expanded broad-spectrum IV antibiotic that can be used for the treatment of a wide range of infections including those caused by ... -MedIndia

Antibiotic use backed in MRSA fight  Jul 11, 2006
The Scottish Medicines Consortium (SMC) is recommending using the antibiotic Tygacil, also known as tigecycline, to treat severe hospital infections. ... -ic Ayrshire.co.uk

Scots to get first use of superdrug  Jul 11, 2006
A new drug, tigecycline, has been approved by the Scottish Medicines Consortium for use in patients who do not respond to more common antibiotics. ... -Glasgow Evening Times

Dr. George Ellestad Receives ACS Medicinal Chemistry Award  Jun 28, 2006
This insight was further expanded by the medicinal chemistry team as part of the strategy which led to the discovery of Tygacil® (tigecycline), the first in a ... -Yahoo! News



New Broad-spectrum Antibiotic Tygacil* (tigecycline) Receives ...  May 4, 2006
Tygacil* (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe. Tygacil is produced by Wyeth ... - Medical News Today

New Broad-spectrum Antibiotic Tygacil (tigecycline) Receives ...  May 3, 2006
MAIDENHEAD, England, May 2, 2006 – Tygacil* (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe . ... - PharmaLive.com

New Broad-Spectrum Antibiotic Tygacil[x] (tigecycline) Receives ...  May 2, 2006
Tygacil[x] (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe. Tygacil is produced by ... - PR Newswire UK

International Approvals: Tygacil, DepoDur, and Zyvox  May 8, 2006
May 8, 2006 — The European Commission has approved tigecycline injection for the treatment of complicated intra-abdominal infections and complicated skin and ... - Medscape (subscription)

Natural Products Reemerge  May 10, 2006
...changed. Last June, Wyeth launched Tygacil (tigecycline IV), which Koehn says is a fifth or sixth generation tetracycline. "While ... - Drug Discovery & Development (subscription)

(PRN) - RR Donnelley Reports First-Quarter 2006 Results ... [+]  May 2, 2006
Obligations ... [+. PRN) - New Broad-Spectrum Antibiotic Tygacil[x] (tigecycline) Receives Approval for Use in Europe Today ... [+. ... - Bolsamania.com

Bad Bugs, Few Drugs  May 3, 2006
A chilling example is the delay of an injectable antibiotic called Tigecycline, for infections caused by antibiotic-resistant pathogens. ... - TCS Daily

Novel antibiotic from Wyeth gets green light in Europe  May 3, 2006
Tygacil (tigecycline) has been approved by the European Medicines Agency for use in complicated infections of the skin and soft tissue and complicated intra ... - Pharma Times (subscription)





Tigecycline in Vitro Activity Against Often Difficult to Treat ...  Apr 4, 2006
NICE, FRANCE -- April 4, 2006 -- The activity of the new glycylcycline antibiotic tigecycline (GAR-936) against a wide spectrum of pathogens shows promise for ... - DG News

11th Annual Antibacterial Drug Discovery & Development Summit ...  Mar 24, 2006
Sessions focus on pre-clinical and clinical development, including clinical updates on Dalbavancin from Pfizer, Tigecycline from Wyeth, and Televancin from ... - HTScreening



CMPH - Initial Marketing Authorisation Applications,Europe ...  Feb 24, 2006
...fractures. EMEA review began on 14 March 2005 with an active review time of 224 days. -- Tygacil (tigecycline), Wyeth Europa Ltd. Tygacil ... - Medical News Today,

Scientists re-engineer antibiotic to counter drug resistance  Feb 9, 2006
The product, tigecycline (Tygacil) joins the oxazolidinones, (Pfizer's linezolid) and lipopeptides (Cubist's daptomycin) in a small but growing arsenal against ... - DrugResearcher.com,

Scientists re-engineer antibiotic to counter drug resistance  09 Feb 2006
The product, tigecycline (Tygacil) joins the oxazolidinones, (Pfizer's linezolid) and lipopeptides (Cubist's daptomycin) in a small but growing arsenal against ... - DrugResearcher.com

Antibiotic-Resistant Bacteria May Aid Drug Search, Study Says  Jan 19, 2006
...lung and sinus infections. Tygacil, or tigecycline, made by Madison, New Jersey-based Wyeth, is even newer. The FDA approved it ... - Bloomberg

Digging up clues in fight against antiobiotic-resistant germs  Jan 19, 2006
...and Drug Administration. The drugs, telithromycin and tigecycline, have not been widely used in patients. Wright said: "Studying ... - Scripps Howard News Service

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional